News
Uniogen GenomEra GBS Assay Kit: an easy solution for GBS testing
8.3.2024
Antti-Heikki Tapio, a member of Uniogen’s R&D team, shares his inspiring journey in biotechnology and the background of the GenomEra…
Read more
GenomEra® Assay Kits can recognize “bird flu” H5N1 in humans
7.9.2023
The world is currently going through its worst ever outbreak of bird flu. Uniogen’s GenomEra® Assay Kits detecting influenza A…
Read more
Flu season is here – Let’s talk about testing
2.2.2023
As the flu season is upon us, it might be a good moment to talk about PCR testing. Our Clinical…
Read more
Spring comes with inspiring events
1.2.2023
The merger of Uniogen was completed by the end of 2022 and the three companies became one. We are excited…
Read more
GenomEra® CDX system awarded with the Finnish Engineering Award
24.11.2022
Uniogen is happy to announce that the GenomEra® CDX system by Abacus Diagnostica has been awarded with the Finnish Engineering…
Read more
Meet us at Laboratory Medicine and Exhibition 2022 in Helsinki
30.9.2022
After the COVID-restrictions have loosened it’s fantastic to be able to meet colleagues, share experiences and insight and of course…
Read more
GenomEra® – Over two decades of development to enable diagnosis at the first appointment today
1.9.2022
Uniogen is proud of the journey that has led to a great product – the GenomEra® CDX System. The automated molecular diagnostics…
Read more
New GenomEra® assay kit for rapid detection of viruses causing viral meningitis CE-marked
6.7.2022
Abacus Diagnostica launches new GenomEra® assay kit for rapid detection of viruses causing viral meningitis Abacus Diagnostica, a Uniogen company…
Read more
A pioneer of global diagnostics – made in Finland
17.6.2022
As a company with strong roots in Turku, Finland, Uniogen is proud to announce that Abacus Diagnostica’s GenomEra® products now…
Read more
GenomEra® 2.0 assay kit for COVID-19 CE marked
10.2.2022
The Finnish diagnostics company Abacus Diagnostica, part of Uniogen, is launching its second- generation COVID-19 test, the GenomEra® SARS-CoV-2 2.0…
Read more